Pharm Res. 1991 Jul;8(7):807-14.

The nasal mucociliary clearance: relevance to nasal drug delivery.

Source

Center for Bio-Pharmaceutical Sciences, Leiden University, The Netherlands.

Abstract

Mucociliary clearance is an important physiological defense mechanism of the respiratory tract to protect the body against noxious inhaled materials. This process is responsible for the rapid clearance of nasally administered drugs from the nasal cavity to the nasopharynx, thereby interfering with the absorption of drugs following intranasal application. This review describes the mucociliary system and the methods used for its characterization. Examples are given of the effects of drugs and additives on its functioning. Further, possible approaches are presented for increasing the residence time of drugs in the nasal cavity, thereby improving intranasal drug delivery.

PMID:: 1924131; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Nasal mucociliary clearance as a factor in nasal drug delivery. [Adv Drug Deliv Rev. 1998]
Nasal mucociliary clearance as a factor in nasal drug delivery.
Merkus FW, Verhoef JC, Schipper NG, Marttin E. Adv Drug Deliv Rev. 1998 Jan 5; 29(1-2):13-38.
Influence of the nasal mucociliary system on intranasal drug administration. [Chin Med J (Engl). 2000]
Influence of the nasal mucociliary system on intranasal drug administration.
Wang J, Bu G. Chin Med J (Engl). 2000 Jul; 113(7):647-9.
Review Nasal clearance in health and disease. [J Aerosol Med. 2006]
Review Nasal clearance in health and disease.
Illum L. J Aerosol Med. 2006 Spring; 19(1):92-9.
Review Nasal delivery of high molecular weight drugs. [Molecules. 2009]
Review Nasal delivery of high molecular weight drugs.
Ozsoy Y, Gungor S, Cevher E. Molecules. 2009 Sep 23; 14(9):3754-79. Epub 2009 Sep 23.
Review Nasal route and drug delivery systems. [Pharm World Sci. 2004]
Review Nasal route and drug delivery systems.
Türker S, Onur E, Ozer Y. Pharm World Sci. 2004 Jun; 26(3):137-42.

See reviews... See all...

Cited by 2 PubMed Central articles

A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs. [Pharm Res. 2009]
A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs.
Stevens J, Suidgeest E, van der Graaf PH, Danhof M, de Lange EC. Pharm Res. 2009 Aug; 26(8):1911-7. Epub 2009 May 19.
In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity. [FEMS Microbiol Lett. 2007]
In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity.
Irie Y, Yuk MH. FEMS Microbiol Lett. 2007 Oct; 275(2):191-8. Epub 2007 Aug 22.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The nasal mucociliary clearance: relevance to nasal drug delivery.
The nasal mucociliary clearance: relevance to nasal drug delivery.
Pharm Res. 1991 Jul ;8(7):807-14.

PubMed
Modified central aortopulmonary shunt with end-to-end anastomosis of the shunt t...
Modified central aortopulmonary shunt with end-to-end anastomosis of the shunt to the pulmonary trunk: Early results of a novel shunt procedure for first-stage palliation of infants with pulmonary atresia and hypoplastic pulmonary arteries.
Thorac Cardiovasc Surg. 2009 Mar ;57(2):85-90. Epub 2009 Feb 24 .

PubMed
The neurological complications of cardiac transplantation.
The neurological complications of cardiac transplantation.
Brain. 1976 Dec ;99(4):673-94.

PubMed
Endothelial progenitor cells and cardiovascular cell-based therapies.
Endothelial progenitor cells and cardiovascular cell-based therapies.
Cytotherapy. 2009 ;11(2):103-13.

PubMed
Production of taxa-4(5),11(12)-diene by transgenic Physcomitrella patens.
Production of taxa-4(5),11(12)-diene by transgenic Physcomitrella patens.
Transgenic Res. 2009 Aug ;18(4):655-60. Epub 2009 Feb 25 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: